Literature DB >> 22800544

Risk factors for the development of primary cutaneous melanoma.

Julie E Russak1, Darrell S Rigel.   

Abstract

Melanoma is an important public health problem in the United States and worldwide. The incidence of melanoma continues to increase at a high rate and deaths from melanoma are also increasing. The endogenous risk factors that are currently recognized are in many cases surrogates for genetic markers yet to be determined. Exogenous risk factors need to be better defined and understood to help develop better public education programs that can change risk behaviors and subsequently lower future incidence and mortality from melanoma.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22800544     DOI: 10.1016/j.det.2012.05.002

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

1.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

2.  Prevalence and Mortality of Melanoma in Oklahoma Among Racial Groups, 2000-2008.

Authors:  Jonathan Baldwin; Amanda E Janitz; Julie Erb-Alvarez; Cuyler Snider; Janis E Campbell
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

3.  Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.

Authors:  Elliot J Coups; Sharon L Manne; Pamela Ohman Strickland; Michelle Hilgart; James S Goydos; Carolyn J Heckman; Paola Chamorro; Babar K Rao; Moira Davis; Franz O Smith; Frances P Thorndike; Lee M Ritterband
Journal:  Contemp Clin Trials       Date:  2019-06-27       Impact factor: 2.226

Review 4.  Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Authors:  Monica Marzagalli; Marina Montagnani Marelli; Lavinia Casati; Fabrizio Fontana; Roberta Manuela Moretti; Patrizia Limonta
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-26       Impact factor: 5.555

5.  A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.

Authors:  Jae-Rim Heo; Kyung-A Hwang; Seung U Kim; Kyung-Chul Choi
Journal:  Cancer Res Treat       Date:  2018-09-14       Impact factor: 4.679

6.  Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.

Authors:  Yoana Arroyo-Berdugo; Santos Alonso; Gloría Ribas; Maider Ibarrola-Villava; María Peña-Chilet; Conrado Martínez-Cadenas; Jesús Gardeazabal; Juan Antonio Ratón-Nieto; Ana Sánchez-Díez; Jesús María Careaga; Gorka Pérez-Yarza; Gregorio Carretero; Manuel Martín-González; Cristina Gómez-Fernández; Eduardo Nagore; Aintzane Asumendi; María Dolores Boyano
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

7.  An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa.

Authors:  Johann de Wet; Minette Steyn; Henry F Jordaan; Rhodine Smith; Saskya Claasens; Willem I Visser
Journal:  J Skin Cancer       Date:  2020-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.